Transcranial Magnetic Stimulation (TMS) – FuturiZe discussion and demo

Despite recent advances in understanding the neurobiology of addiction, the currently available evidence-based pharmacological and biopsychosocial therapies mainly target abstinence, and have shown only a moderate effect on reducing craving and relapse. In the search for new treatment approaches, non-invasive neuromodulation has shown promise, with the ability to rebalance specific disturbed neurological processes and improve executive function. Transcranial Magnetic Stimulation (TMS) can target and modulate specific brain circuits involved in the neuropathology of addiction, and thus represents a non-pharmacological and testable tool in the treatment of substance use disorders. A TMS therapy system will be exhibited throughout the duration of Lisbon Addictions 2019 in the Terrace Room, Futures Zone.

In this activity, an introduction to the state of the art of TMS, its basic mechanisms, and device operation will be offered by Dr Graziella Madeo (Scientific Coordinator at Fondazione Novella Fronda, Studio Gallimberti-Bonci) and Kasper Bredkær Sidenius (Application Specialist at MagVenture), followed by a discussion on its applications and use in addictions. The demonstration will be performed using the TMS therapy system exhibited in the room and with the help of a volunteer from the participants.

The workshop is organised as part of the EC co-funded project FuturiZe (http://www.lx-futurize.eu).
Places in the workshop are limited and registration is required: https://www.eventbrite.co.uk/o/futurize-26821812555